Quarterly report pursuant to Section 13 or 15(d)

Note 4 - Balance Sheet Details

v3.6.0.2
Note 4 - Balance Sheet Details
9 Months Ended
Jan. 01, 2017
Notes to Financial Statements  
Supplemental Balance Sheet Disclosures [Text Block]
NOTE
4.
BALANCE SHEET DETAILS
 
Our inventories consisted of the following as of the dates indicated (in thousands):
 
 
 
January 1,
 
 
March 27,
 
 
 
2017
 
 
2016
 
Raw materials
  $
1,252
    $
1,012
 
Work-in-progress
   
9,729
     
9,780
 
Finished goods
   
13,240
     
10,015
 
Total inventories
  $
24,221
    $
20,807
 
 
Our property, plant and equipment consisted of the following as of the dates indicated below (in thousands):
 
 
 
January 1,
 
 
March 27,
 
 
 
2017
 
 
2016
 
Land
  $
-
    $
6,660
 
Building
   
-
     
16,365
 
Machinery and equipment
   
38,214
     
37,813
 
Software and licenses
   
21,561
     
22,045
 
Leasehold Improvement
   
833
     
755
 
Property, plant and equipment, total
   
60,608
     
83,638
 
Accumulated depreciation, amortization and impairment
   
(56,682
)    
(63,339
)
Total property, plant and equipment, net
  $
3,926
    $
20,299
 
 
The decrease in land and building relates to the sale-leaseback of our Fremont facility. The accumulated depreciation and amortization for the
three
and
nine
months ended
January
1,
2017
includes a
$1.0
million and
$2.5
million, respectively, write down for impaired design tools. See
“Note
13
- Lease Financing Obligation.”
   
 
Our other current liabilities consisted of the following as of the dates indicated (in thousands):
 
 
 
January 1,
 
 
March 27,
 
 
 
2017
 
 
2016
 
Short-term lease financing obligations
  $
1,714
    $
3,784
 
Deferred gain on sale of land and building under sale-leaseback arrangement
   
1,594
     
-
 
Accrual for stock awards in connection with Cadeka acquisition
   
1,200
     
1,200
 
Purchase consideration holdback
   
1,006
     
1,006
 
Accrued sales and marketing expenses
   
894
     
699
 
Accrued legal and professional services
   
792
     
1,247
 
Accrued manufacturing expenses, royalties and licenses
   
674
     
486
 
Accrued restructuring charges and exit costs
   
157
     
494
 
Other current liabilities
   
2,169
     
1,753
 
Total other current liabilities
  $
10,200
    $
10,669
 
 
 
 
Our other non-current obligations consisted of the following as of the dates indicated (in thousands):
 
 
 
January 1,
 
 
March 27,
 
 
 
2017
 
 
2016
 
Long-term taxes payable
  $
3,446
    $
3,339
 
Deferred tax liability
   
90
     
83
 
Total other non-current obligations
  $
3,536
    $
3,422
 
 
The deferred gain included in other current liabilities and non-current obligations relates to deferred gain associated with our sale-leaseback, net of amortization.
See “
Note
13.
Lease Financing Obligations”.